• anvajo

  Participated · Series A · Oct 2022

  anvajo develops and sells a portable point-of-care fluid analysis platform called the “fluidlab,” which combines spectroscopy and microscopy with custom sample carriers. The fluidlab integrates holographic microscopy, machine‑learning‑supported image analysis, mobile embedded hardware, function‑integrated optics, and meso‑ and micro‑fluidic sample carriers. The company positions the device for use in human and veterinary medicine as well as environmental, water, food and feed analysis. anvajo says the system can deliver fast diagnostic testing of blood, urine and sperm immediately at the point of need. The company is a spin‑off from Dresden University of Technology and is led by CEO Felix Lambrecht; Stefan Fraedrich founded the business. Financially, the firm announced a €17.7M Series A to support its planned launch into human medicine markets.

No current team members are available.